Ulrike Werthmann
17Patents
5h-index
39Co-inventors
66Inventor score
Filing activity: Jun 11, 2002 → Mar 11, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6608055B2 | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition | Chemistry; Metallurgy | 16 | Expired |
| US8609670B2 | Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma | Chemistry; Metallurgy | 9 | Active |
| US10213428B2 | (4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrate | Chemistry; Metallurgy | 6 | Active |
| US8742115B2 | Co-crystals and salts of CCR3-inhibitors | Chemistry; Metallurgy | 6 | Active |
| US9233950B2 | Co-crystals and salts of CCR3-inhibitors | Chemistry; Metallurgy | 5 | Active |
| US10568885B2 | (4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-y1)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-citrate | Chemistry; Metallurgy | 5 | Active |
| US11147814B2 | (4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p- tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrate | Chemistry; Metallurgy | 3 | Active |
| US11306086B2 | Crystalline salts of a B-RAF kinase inhibitor | Chemistry; Metallurgy | 1 | Active |
| US9802954B2 | Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma | Chemistry; Metallurgy | 1 | Active |
| US12076321B2 | (4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrate | Chemistry; Metallurgy | 0 | Active |
| US10745411B2 | Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma | Chemistry; Metallurgy | 0 | Active |
| US11753409B2 | Crystalline salts of a B-RAF kinase inhibitor | Chemistry; Metallurgy | 0 | Active |
| US10919898B2 | Medical use of compound III | Chemistry; Metallurgy | 0 | Active |
| US8551987B2 | Crystalline ethyl 4-[4-[(2R)-3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-oxo-2-[[[4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]oxy]propyl]-1-piperazinyl]-piperidine-1-acetate difumarate | Human Necessities | 0 | Active |
| US7638625B2 | Crystalline compounds | Chemistry; Metallurgy | 0 | Active |
| US8394791B2 | Crystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drug | Human Necessities | 0 | Active |
| US9150586B2 | Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.